Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.59) per share. This is a 11.32 percent decrease over losses of $(0.53) per share from the same period last year.
Loews Corporation Announces Reversal Of Trial Court Decision In Boardwalk Pipelines Acquisition Litigation
Loews Corporation (NYSE:L) announced today that the Delaware Supreme Court reversed the November 2021 decision of the Delaware Court of Chancery that had awarded former minority unitholders in its
